NIH-funded research NIH-funded research

Advanced metabolomics tools to study deadly brain infection organisms

Official title: Development of High-Resolution Ion Mobility and Tandem Mass Spectrometry Approaches for Advanced Metabolomic Characterization of Eukaryotic Pathogenic Systems

Funded at Clemson University · NIH-11382802 · Data updated 2026-11-12

Researchers will use high-resolution ion mobility and tandem mass spectrometry to better understand the metabolites involved in infections caused by brain-threatening pathogens like Naegleria fowleri and Aspergillus fumigatus, with potential to improve diagnosis and treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startJuly 15, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$260,710
NIH project number5P20GM146584-05
Project IDNIH-11382802 on NIH RePORTER

Who could benefit from this research

Could help

Individuals at risk for or suffering from Naegleria fowleri or Aspergillus fumigatus infections, or clinicians seeking better diagnostic markers, would be relevant.

Less likely to help

People not exposed to these infections or not receiving diagnostic/metabolomic research may see little direct benefit.

What this research studies

This project focuses on the challenging metabolomics of two dangerous pathogens that affect people, especially those with weakened immune systems. By applying cutting-edge mass spectrometry and ion mobility techniques, the team aims to capture a broad and detailed view of metabolites during infection and treatment. The work is conducted at Clemson University under the Center of Biomedical Research Excellence (COBRE) framework, linking advanced technology with infectious disease biology. The goal is to uncover metabolite patterns that could inform better diagnostic tools and therapeutic strategies.

Why it matters

Potential benefit: If successful, patients could benefit from faster, more accurate diagnostics and new avenues for targeted therapies against these tough brain and respiratory infections.

How similar studies have gone: Previous advances in ion mobility and high-resolution MS have improved metabolite detection, suggesting this approach could yield meaningful insights for these pathogens.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Chouinard, Christopher Donald — Clemson University
  • Study coordinator: Chouinard, Christopher Donald

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.